Mast cell activation syndrome (MCAS) affects more than 15% of the U.S. population but evades most practitioners’ radar. Just five years ago, it wasn’t even on my radar, despite already having 20 years of experience as a clinician at that time. The more I dug (similar to leaky gut and post-COVID syndrome), the more I found my patients were suffering from this disorder.
Sign Up for our Free Newsletters
Subscribe, Unsubscribe, or Update your email address for AT Newsletter below.
News Update
Subscribe to AT Newsletter
Unsubscribe from AT News Update
Update your email address to AT Newsletter